| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.80e-08 | 16 | 47 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.57e-07 | 21 | 47 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | integrin binding | 1.65e-07 | 175 | 47 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.01e-06 | 188 | 47 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor binding | 8.12e-06 | 17 | 47 | 3 | GO:0005172 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.35e-05 | 20 | 47 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | coreceptor activity | 2.46e-05 | 72 | 47 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.74e-05 | 85 | 47 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 7.01e-05 | 599 | 47 | 8 | GO:0050839 | |
| GeneOntologyMolecularFunction | neuregulin binding | 8.09e-05 | 6 | 47 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.32e-04 | 42 | 47 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor 2 binding | 2.41e-04 | 10 | 47 | 2 | GO:0043184 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 2.79e-04 | 54 | 47 | 3 | GO:0042056 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 4.16e-04 | 13 | 47 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | growth factor binding | 4.92e-04 | 156 | 47 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 6.77e-04 | 73 | 47 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 7.21e-04 | 17 | 47 | 2 | GO:0005161 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 7.26e-04 | 173 | 47 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 9.04e-04 | 19 | 47 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.07e-03 | 192 | 47 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 1.22e-03 | 22 | 47 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 1.22e-03 | 22 | 47 | 2 | GO:0003756 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.73e-03 | 749 | 47 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.83e-03 | 27 | 47 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | fibronectin binding | 3.61e-03 | 38 | 47 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.55e-03 | 891 | 47 | 7 | GO:0005198 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.42e-03 | 51 | 47 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 7.97e-03 | 57 | 47 | 2 | GO:0016860 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 8.03e-03 | 337 | 47 | 4 | GO:0001664 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 9.01e-03 | 547 | 47 | 5 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 9.49e-03 | 554 | 47 | 5 | GO:0030546 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | LRP1 TRIOBP LAMB2 PPARD TEK ITGB3 ITGB4 PREX1 TNXB ITGB7 VEGFA | 1.96e-09 | 410 | 48 | 11 | GO:0031589 |
| GeneOntologyBiologicalProcess | trophoblast cell migration | 1.22e-07 | 20 | 48 | 4 | GO:0061450 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 1.84e-07 | 108 | 48 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.94e-07 | 109 | 48 | 6 | GO:0034446 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 2.67e-07 | 115 | 48 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 6.82e-07 | 577 | 48 | 10 | GO:0001667 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.84e-06 | 270 | 48 | 7 | GO:0007160 | |
| GeneOntologyBiologicalProcess | embryo implantation | 3.02e-06 | 97 | 48 | 5 | GO:0007566 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | VEGFC FBN2 TENM3 WNT7B WNT8A LAMA3 TRIOBP LRP4 LRP6 LAMB2 TEK ITGB4 VEGFA | 4.34e-06 | 1269 | 48 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | VEGFC STAB2 FBN2 CD9 RHOJ WNT7B WNT8A LRP6 ESM1 TEK ITGB3 ITGB4 PGM5 VEGFA | 4.38e-06 | 1483 | 48 | 14 | GO:0048646 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CD9 TENM3 WNT7B LAMA3 LRP6 TEK ITGB3 ITGB4 TNXB ITGB7 TSPAN9 VEGFA | 4.69e-06 | 1077 | 48 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of cell motility | VEGFC FBN2 PHPT1 CD9 RHOJ LRP1 LAMA3 PPARD TEK ITGB3 PREX1 TNXB VEGFA | 4.77e-06 | 1280 | 48 | 13 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | CD9 TENM3 LRP1 LAMA3 TRIOBP LAMB2 TEK ITGB3 PREX1 TNXB VEGFA | 6.98e-06 | 927 | 48 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of locomotion | VEGFC FBN2 PHPT1 CD9 RHOJ LRP1 LAMA3 PPARD TEK ITGB3 PREX1 TNXB VEGFA | 7.06e-06 | 1327 | 48 | 13 | GO:0040012 |
| GeneOntologyBiologicalProcess | cell junction organization | 1.11e-05 | 974 | 48 | 11 | GO:0034330 | |
| GeneOntologyBiologicalProcess | regulation of trophoblast cell migration | 1.12e-05 | 19 | 48 | 3 | GO:1901163 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.21e-05 | 337 | 48 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | VEGFC FBN2 CD9 RHOJ LRP1 LAMA3 PPARD TEK ITGB3 PREX1 TNXB VEGFA | 1.54e-05 | 1211 | 48 | 12 | GO:0030334 |
| GeneOntologyBiologicalProcess | response to wounding | 1.81e-05 | 659 | 48 | 9 | GO:0009611 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor signaling pathway | 2.00e-05 | 69 | 48 | 4 | GO:0048010 | |
| GeneOntologyBiologicalProcess | female pregnancy | 2.34e-05 | 249 | 48 | 6 | GO:0007565 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell migration | 2.37e-05 | 148 | 48 | 5 | GO:0010595 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 2.45e-05 | 149 | 48 | 5 | GO:0010811 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 2.62e-05 | 254 | 48 | 6 | GO:0010810 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 2.78e-05 | 75 | 48 | 4 | GO:0050918 | |
| GeneOntologyBiologicalProcess | neuron projection development | TENM3 WNT7B LRP1 LAMA3 TRIOBP LRP4 LRP6 LAMB2 PREX1 TNXB TSPAN2 VEGFA | 2.78e-05 | 1285 | 48 | 12 | GO:0031175 |
| GeneOntologyBiologicalProcess | trachea cartilage morphogenesis | 3.17e-05 | 4 | 48 | 2 | GO:0060535 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphangiogenesis | 3.17e-05 | 4 | 48 | 2 | GO:1901492 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 4.34e-05 | 84 | 48 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.38e-05 | 412 | 48 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 4.56e-05 | 569 | 48 | 8 | GO:0034329 | |
| GeneOntologyBiologicalProcess | nephron development | 5.15e-05 | 174 | 48 | 5 | GO:0072006 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 5.28e-05 | 5 | 48 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 5.28e-05 | 5 | 48 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 5.41e-05 | 426 | 48 | 7 | GO:0043010 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 5.48e-05 | 290 | 48 | 6 | GO:0044703 | |
| GeneOntologyBiologicalProcess | trabecula formation | 5.59e-05 | 32 | 48 | 3 | GO:0060343 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 5.91e-05 | 294 | 48 | 6 | GO:0044706 | |
| GeneOntologyBiologicalProcess | gliogenesis | 6.17e-05 | 435 | 48 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | RHOJ WNT7B WNT8A LRP1 LAMA3 TRIOBP LRP4 LRP6 LAMB2 ITGB3 VEGFA | 7.27e-05 | 1194 | 48 | 11 | GO:0000902 |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 7.91e-05 | 6 | 48 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 7.91e-05 | 6 | 48 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | embryo development | VEGFC FBN2 WNT7B WNT8A LAMA3 TRIOBP LRP4 LRP6 UBR3 LRP1B ITPK1 VEGFA | 8.27e-05 | 1437 | 48 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 9.60e-05 | 817 | 48 | 9 | GO:0048514 | |
| GeneOntologyBiologicalProcess | neuron development | TENM3 WNT7B LRP1 LAMA3 TRIOBP LRP4 LRP6 LAMB2 PREX1 TNXB TSPAN2 VEGFA | 9.82e-05 | 1463 | 48 | 12 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell migration | 1.04e-04 | 202 | 48 | 5 | GO:0010634 | |
| GeneOntologyBiologicalProcess | endocytosis | 1.05e-04 | 827 | 48 | 9 | GO:0006897 | |
| GeneOntologyBiologicalProcess | regulation of lymphangiogenesis | 1.11e-04 | 7 | 48 | 2 | GO:1901490 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell chemotaxis | 1.11e-04 | 7 | 48 | 2 | GO:0060754 | |
| GeneOntologyBiologicalProcess | eye development | 1.14e-04 | 480 | 48 | 7 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 1.19e-04 | 483 | 48 | 7 | GO:0150063 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 1.22e-04 | 209 | 48 | 5 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 1.22e-04 | 209 | 48 | 5 | GO:0007272 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.31e-04 | 491 | 48 | 7 | GO:0048880 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial growth factor receptor signaling pathway | 1.46e-04 | 44 | 48 | 3 | GO:0030947 | |
| GeneOntologyBiologicalProcess | trachea cartilage development | 1.47e-04 | 8 | 48 | 2 | GO:0060534 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.47e-04 | 8 | 48 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | response to hypoxia | 1.49e-04 | 348 | 48 | 6 | GO:0001666 | |
| GeneOntologyBiologicalProcess | sprouting angiogenesis | 1.55e-04 | 220 | 48 | 5 | GO:0002040 | |
| GeneOntologyBiologicalProcess | positive regulation of substrate adhesion-dependent cell spreading | 1.67e-04 | 46 | 48 | 3 | GO:1900026 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.78e-04 | 47 | 48 | 3 | GO:0014002 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular endothelial growth factor signaling pathway | 1.89e-04 | 9 | 48 | 2 | GO:1900748 | |
| GeneOntologyBiologicalProcess | regulation of mast cell chemotaxis | 1.89e-04 | 9 | 48 | 2 | GO:0060753 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 1.90e-04 | 364 | 48 | 6 | GO:0036293 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.97e-04 | 124 | 48 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell proliferation | 2.03e-04 | 125 | 48 | 4 | GO:0001938 | |
| GeneOntologyBiologicalProcess | angiogenesis | 2.07e-04 | 708 | 48 | 8 | GO:0001525 | |
| GeneOntologyBiologicalProcess | kidney development | 2.14e-04 | 372 | 48 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.14e-04 | 372 | 48 | 6 | GO:0060485 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.18e-04 | 911 | 48 | 9 | GO:0048589 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.19e-04 | 1125 | 48 | 10 | GO:0035239 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 2.23e-04 | 128 | 48 | 4 | GO:0034103 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor signaling pathway | 2.28e-04 | 51 | 48 | 3 | GO:0038084 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 2.44e-04 | 725 | 48 | 8 | GO:2000147 | |
| GeneOntologyBiologicalProcess | blood vessel development | 2.52e-04 | 929 | 48 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | sensory organ development | 2.55e-04 | 730 | 48 | 8 | GO:0007423 | |
| GeneOntologyBiologicalProcess | renal system development | 2.61e-04 | 386 | 48 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 2.85e-04 | 742 | 48 | 8 | GO:0040017 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 2.98e-04 | 747 | 48 | 8 | GO:0007169 | |
| GeneOntologyBiologicalProcess | tube development | 3.00e-04 | 1402 | 48 | 11 | GO:0035295 | |
| GeneOntologyBiologicalProcess | ossification | 3.00e-04 | 562 | 48 | 7 | GO:0001503 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 3.17e-04 | 57 | 48 | 3 | GO:0061383 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 3.22e-04 | 141 | 48 | 4 | GO:0001952 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 3.35e-04 | 1186 | 48 | 10 | GO:0007167 | |
| GeneOntologyBiologicalProcess | vasculature development | 3.45e-04 | 969 | 48 | 9 | GO:0001944 | |
| GeneOntologyBiologicalProcess | cartilage morphogenesis | 3.45e-04 | 12 | 48 | 2 | GO:0060536 | |
| GeneOntologyBiologicalProcess | trachea morphogenesis | 3.45e-04 | 12 | 48 | 2 | GO:0060439 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 3.59e-04 | 579 | 48 | 7 | GO:0045785 | |
| GeneOntologyBiologicalProcess | circulatory system development | VEGFC CRELD1 STAB2 RHOJ WNT7B LRP1 LRP6 ESM1 TEK ITGB3 VEGFA | 3.82e-04 | 1442 | 48 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 3.94e-04 | 269 | 48 | 5 | GO:0010594 | |
| GeneOntologyBiologicalProcess | epithelium development | VEGFC WNT7B TRIOBP LRP4 LRP6 LAMB2 PPARD TEK ITGB3 ITPK1 VEGFA | 4.47e-04 | 1469 | 48 | 11 | GO:0060429 |
| GeneOntologyBiologicalProcess | response to oxygen levels | 4.64e-04 | 430 | 48 | 6 | GO:0070482 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 4.74e-04 | 14 | 48 | 2 | GO:0098953 | |
| GeneOntologyBiologicalProcess | bone trabecula formation | 4.74e-04 | 14 | 48 | 2 | GO:0060346 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 4.75e-04 | 432 | 48 | 6 | GO:0010631 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 4.83e-04 | 803 | 48 | 8 | GO:0030036 | |
| GeneOntologyBiologicalProcess | glial cell development | 4.84e-04 | 157 | 48 | 4 | GO:0021782 | |
| GeneOntologyBiologicalProcess | regulation of substrate adhesion-dependent cell spreading | 4.88e-04 | 66 | 48 | 3 | GO:1900024 | |
| GeneOntologyBiologicalProcess | epithelium migration | 4.93e-04 | 435 | 48 | 6 | GO:0090132 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.12e-04 | 285 | 48 | 5 | GO:0007411 | |
| GeneOntologyCellularComponent | extracellular matrix | CRELD1 FCGBP FBN2 WNT8A LAMA3 LAMB2 CTSB ITGB4 TNXB FBN3 TSPAN9 VEGFA | 2.04e-08 | 656 | 48 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CRELD1 FCGBP FBN2 WNT8A LAMA3 LAMB2 CTSB ITGB4 TNXB FBN3 TSPAN9 VEGFA | 2.11e-08 | 658 | 48 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | cell-substrate junction | 5.26e-08 | 443 | 48 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.35e-07 | 59 | 48 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.78e-07 | 530 | 48 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | focal adhesion | 5.10e-07 | 431 | 48 | 9 | GO:0005925 | |
| GeneOntologyCellularComponent | cell surface | TNFRSF9 STAB2 CD9 WNT7B LRP1 LRP4 LRP6 TEK CTSB ITGB3 ITGB4 ITGB7 VEGFA | 8.52e-07 | 1111 | 48 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | anchoring junction | CD9 LRP1 LAMA3 TRIOBP TEK ITGB3 ITGB4 ITGB7 TSPAN9 PGM5 VEGFA | 1.00e-05 | 976 | 48 | 11 | GO:0070161 |
| GeneOntologyCellularComponent | laminin-3 complex | 1.55e-05 | 3 | 48 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | integrin complex | 5.38e-05 | 32 | 48 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | platelet alpha granule | 6.15e-05 | 93 | 48 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | basement membrane | 1.76e-04 | 122 | 48 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 2.30e-04 | 10 | 48 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | hemidesmosome | 2.80e-04 | 11 | 48 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | microfibril | 3.96e-04 | 13 | 48 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | platelet alpha granule membrane | 6.87e-04 | 17 | 48 | 2 | GO:0031092 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 6.87e-04 | 17 | 48 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | side of membrane | 7.78e-04 | 875 | 48 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.15e-03 | 519 | 48 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.41e-03 | 212 | 48 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | secretory granule | 2.00e-03 | 1014 | 48 | 8 | GO:0030141 | |
| GeneOntologyCellularComponent | receptor complex | 2.05e-03 | 581 | 48 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | apical part of cell | 2.25e-03 | 592 | 48 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | plasma membrane raft | 4.68e-03 | 147 | 48 | 3 | GO:0044853 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.05e-03 | 487 | 48 | 5 | GO:0016324 | |
| GeneOntologyCellularComponent | secretory vesicle | 6.98e-03 | 1246 | 48 | 8 | GO:0099503 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 8.81e-03 | 785 | 48 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | membrane raft | 9.45e-03 | 362 | 48 | 4 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 9.63e-03 | 364 | 48 | 4 | GO:0098857 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.04e-02 | 67 | 48 | 2 | GO:0031093 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.06e-02 | 583 | 48 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.06e-02 | 817 | 48 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.12e-02 | 591 | 48 | 5 | GO:0005911 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.15e-02 | 384 | 48 | 4 | GO:0030139 | |
| HumanPheno | Atrophic scars | 1.05e-05 | 37 | 20 | 4 | HP:0001075 | |
| MousePheno | abnormal limb development | 6.65e-05 | 140 | 43 | 5 | MP:0006279 | |
| MousePheno | abnormal tumor vascularization | 8.42e-05 | 28 | 43 | 3 | MP:0010144 | |
| MousePheno | abnormal tumor vascular morphology | 8.42e-05 | 28 | 43 | 3 | MP:0021056 | |
| MousePheno | failure of neuromuscular synapse postsynaptic differentiation | 1.38e-04 | 6 | 43 | 2 | MP:0001055 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 1.38e-04 | 6 | 43 | 2 | MP:0001054 | |
| MousePheno | abnormal limb bud morphology | 1.71e-04 | 91 | 43 | 4 | MP:0005650 | |
| MousePheno | abnormal keratinocyte adhesion | 1.92e-04 | 7 | 43 | 2 | MP:0030576 | |
| Domain | EGF_1 | ATRN CRELD1 STAB2 FBN2 TENM3 LRP1 LAMA3 LRP4 LRP6 LAMB2 TEK LRP1B ITGB3 ITGB4 TNXB ITGB7 FBN3 | 3.39e-20 | 255 | 48 | 17 | PS00022 |
| Domain | EGF-like_CS | ATRN CRELD1 STAB2 FBN2 TENM3 LRP1 LAMA3 LRP4 LRP6 LAMB2 TEK LRP1B ITGB3 ITGB4 TNXB ITGB7 FBN3 | 5.05e-20 | 261 | 48 | 17 | IPR013032 |
| Domain | EGF_2 | ATRN CRELD1 STAB2 FBN2 TENM3 LRP1 LAMA3 LRP4 LRP6 LAMB2 TEK LRP1B ITGB3 ITGB4 TNXB ITGB7 FBN3 | 6.55e-20 | 265 | 48 | 17 | PS01186 |
| Domain | Growth_fac_rcpt_ | ATRN CRELD1 TNFRSF9 STAB2 FBN2 LRP1 LAMA3 LRP4 LAMB2 ESM1 TEK LRP1B TNXB FBN3 | 1.68e-18 | 156 | 48 | 14 | IPR009030 |
| Domain | EGF | ATRN CRELD1 STAB2 FCGBP FBN2 TENM3 LRP1 LAMA3 LRP4 LRP6 LAMB2 TEK LRP1B TNXB FBN3 | 1.51e-17 | 235 | 48 | 15 | SM00181 |
| Domain | EGF-like_dom | ATRN CRELD1 STAB2 FCGBP FBN2 TENM3 LRP1 LAMA3 LRP4 LRP6 LAMB2 TEK LRP1B TNXB FBN3 | 3.62e-17 | 249 | 48 | 15 | IPR000742 |
| Domain | EGF_extracell | 2.96e-14 | 60 | 48 | 9 | IPR013111 | |
| Domain | EGF_2 | 2.96e-14 | 60 | 48 | 9 | PF07974 | |
| Domain | EGF_3 | ATRN CRELD1 STAB2 FBN2 TENM3 LRP1 LRP4 LRP6 TEK LRP1B TNXB FBN3 | 5.55e-13 | 235 | 48 | 12 | PS50026 |
| Domain | EGF | 2.91e-11 | 126 | 48 | 9 | PF00008 | |
| Domain | cEGF | 5.72e-09 | 26 | 48 | 5 | IPR026823 | |
| Domain | cEGF | 5.72e-09 | 26 | 48 | 5 | PF12662 | |
| Domain | EGF_CA | 2.52e-08 | 122 | 48 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.82e-08 | 124 | 48 | 7 | IPR001881 | |
| Domain | Ldl_recept_b | 3.77e-08 | 14 | 48 | 4 | PF00058 | |
| Domain | LDLRB | 3.77e-08 | 14 | 48 | 4 | PS51120 | |
| Domain | Laminin_EGF | 4.26e-08 | 38 | 48 | 5 | IPR002049 | |
| Domain | - | 4.88e-08 | 39 | 48 | 5 | 2.120.10.30 | |
| Domain | LY | 5.13e-08 | 15 | 48 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.13e-08 | 15 | 48 | 4 | IPR000033 | |
| Domain | EGF_CA | 8.39e-08 | 86 | 48 | 6 | PF07645 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.15e-07 | 46 | 48 | 5 | IPR011042 | |
| Domain | EGF_Ca-bd_CS | 1.73e-07 | 97 | 48 | 6 | IPR018097 | |
| Domain | EGF_CA | 1.95e-07 | 99 | 48 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.07e-07 | 100 | 48 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.93e-07 | 106 | 48 | 6 | IPR000152 | |
| Domain | Integrin_bsu_tail | 5.54e-07 | 7 | 48 | 3 | IPR012896 | |
| Domain | Integrin_B_tail | 5.54e-07 | 7 | 48 | 3 | SM01242 | |
| Domain | Integrin_B_tail | 5.54e-07 | 7 | 48 | 3 | PF07965 | |
| Domain | Integrin_beta | 8.84e-07 | 8 | 48 | 3 | PF00362 | |
| Domain | INB | 8.84e-07 | 8 | 48 | 3 | SM00187 | |
| Domain | Integrin_bsu_VWA | 8.84e-07 | 8 | 48 | 3 | IPR002369 | |
| Domain | EGF_LAM_2 | 1.00e-06 | 30 | 48 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.00e-06 | 30 | 48 | 4 | PS01248 | |
| Domain | Integrin_bsu | 1.32e-06 | 9 | 48 | 3 | IPR015812 | |
| Domain | Integin_beta_N | 1.32e-06 | 9 | 48 | 3 | IPR033760 | |
| Domain | INTEGRIN_BETA | 1.32e-06 | 9 | 48 | 3 | PS00243 | |
| Domain | PSI_integrin | 1.32e-06 | 9 | 48 | 3 | PF17205 | |
| Domain | Laminin_EGF | 1.90e-06 | 35 | 48 | 4 | PF00053 | |
| Domain | EGF_Lam | 1.90e-06 | 35 | 48 | 4 | SM00180 | |
| Domain | LDLR_class-A_CS | 3.28e-06 | 40 | 48 | 4 | IPR023415 | |
| Domain | PSI | 4.83e-06 | 44 | 48 | 4 | IPR016201 | |
| Domain | Ldl_recept_a | 5.29e-06 | 45 | 48 | 4 | PF00057 | |
| Domain | PSI | 5.79e-06 | 46 | 48 | 4 | SM00423 | |
| Domain | - | 5.79e-06 | 46 | 48 | 4 | 4.10.400.10 | |
| Domain | DUF5050 | 6.47e-06 | 2 | 48 | 2 | IPR032485 | |
| Domain | DUF5050 | 6.47e-06 | 2 | 48 | 2 | PF16472 | |
| Domain | LDLRA_1 | 6.88e-06 | 48 | 48 | 4 | PS01209 | |
| Domain | LDLRA_2 | 7.47e-06 | 49 | 48 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.47e-06 | 49 | 48 | 4 | IPR002172 | |
| Domain | LDLa | 7.47e-06 | 49 | 48 | 4 | SM00192 | |
| Domain | FBN | 1.94e-05 | 3 | 48 | 2 | IPR011398 | |
| Domain | Tetraspanin_CS | 2.05e-05 | 21 | 48 | 3 | IPR018503 | |
| Domain | TM4_1 | 3.97e-05 | 26 | 48 | 3 | PS00421 | |
| Domain | - | 6.44e-05 | 5 | 48 | 2 | 1.10.1450.10 | |
| Domain | CD81_LEL | 6.44e-05 | 5 | 48 | 2 | IPR028977 | |
| Domain | Tetraspanin | 7.50e-05 | 32 | 48 | 3 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 7.50e-05 | 32 | 48 | 3 | IPR008952 | |
| Domain | Tetraspannin | 8.23e-05 | 33 | 48 | 3 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 8.23e-05 | 33 | 48 | 3 | IPR018499 | |
| Domain | Integrin_bsu_cyt_dom | 9.64e-05 | 6 | 48 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 9.64e-05 | 6 | 48 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 9.64e-05 | 6 | 48 | 2 | PF08725 | |
| Domain | PD_growth_factor_CS | 1.35e-04 | 7 | 48 | 2 | IPR023581 | |
| Domain | TB | 1.35e-04 | 7 | 48 | 2 | PF00683 | |
| Domain | - | 1.79e-04 | 8 | 48 | 2 | 3.90.290.10 | |
| Domain | PDGF | 2.30e-04 | 9 | 48 | 2 | PF00341 | |
| Domain | PDGF_2 | 2.30e-04 | 9 | 48 | 2 | PS50278 | |
| Domain | TB | 2.30e-04 | 9 | 48 | 2 | PS51364 | |
| Domain | TB_dom | 2.30e-04 | 9 | 48 | 2 | IPR017878 | |
| Domain | PDGF_1 | 2.30e-04 | 9 | 48 | 2 | PS00249 | |
| Domain | PDGF/VEGF_dom | 2.30e-04 | 9 | 48 | 2 | IPR000072 | |
| Domain | PDGF | 2.30e-04 | 9 | 48 | 2 | SM00141 | |
| Domain | Laminin_N | 7.58e-04 | 16 | 48 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 7.58e-04 | 16 | 48 | 2 | PS51117 | |
| Domain | Laminin_N | 7.58e-04 | 16 | 48 | 2 | PF00055 | |
| Domain | LamNT | 7.58e-04 | 16 | 48 | 2 | SM00136 | |
| Domain | - | 9.09e-04 | 74 | 48 | 3 | 3.40.50.410 | |
| Domain | Wnt | 1.08e-03 | 19 | 48 | 2 | IPR005817 | |
| Domain | Wnt_CS | 1.08e-03 | 19 | 48 | 2 | IPR018161 | |
| Domain | wnt | 1.08e-03 | 19 | 48 | 2 | PF00110 | |
| Domain | WNT1 | 1.08e-03 | 19 | 48 | 2 | SM00097 | |
| Domain | WNT1 | 1.08e-03 | 19 | 48 | 2 | PS00246 | |
| Domain | VWFA | 1.22e-03 | 82 | 48 | 3 | PS50234 | |
| Domain | VWA | 1.31e-03 | 84 | 48 | 3 | SM00327 | |
| Domain | Integrin_dom | 1.87e-03 | 25 | 48 | 2 | IPR032695 | |
| Domain | VWF_A | 2.10e-03 | 99 | 48 | 3 | IPR002035 | |
| Domain | hEGF | 2.34e-03 | 28 | 48 | 2 | PF12661 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.04e-09 | 300 | 39 | 10 | M610 | |
| Pathway | WP_FOCAL_ADHESION | 3.57e-08 | 187 | 39 | 8 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 5.79e-08 | 199 | 39 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.79e-08 | 199 | 39 | 8 | M7253 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.02e-07 | 302 | 39 | 9 | M39719 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.04e-07 | 84 | 39 | 6 | M7098 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.95e-07 | 326 | 39 | 9 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.71e-07 | 339 | 39 | 9 | M39736 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.99e-06 | 76 | 39 | 5 | M27219 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 2.34e-06 | 439 | 39 | 9 | M42563 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 3.18e-06 | 11 | 39 | 3 | M158 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.51e-06 | 46 | 39 | 4 | M239 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.04e-05 | 59 | 39 | 4 | M27218 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.65e-05 | 325 | 39 | 7 | M12868 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 3.34e-05 | 23 | 39 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 3.34e-05 | 23 | 39 | 3 | M47720 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.49e-05 | 72 | 39 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.75e-05 | 73 | 39 | 4 | MM15906 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 4.87e-05 | 26 | 39 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 4.87e-05 | 26 | 39 | 3 | M47719 | |
| Pathway | WP_CANCER_PATHWAYS | 6.09e-05 | 507 | 39 | 8 | M48302 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 6.11e-05 | 28 | 39 | 3 | M47655 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.97e-05 | 258 | 39 | 6 | MM14572 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 7.27e-05 | 381 | 39 | 7 | M48063 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.55e-05 | 30 | 39 | 3 | M27216 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 7.55e-05 | 30 | 39 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 7.55e-05 | 30 | 39 | 3 | M47718 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.01e-04 | 33 | 39 | 3 | M39503 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.43e-04 | 37 | 39 | 3 | M27134 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.43e-04 | 37 | 39 | 3 | M47411 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 2.07e-04 | 8 | 39 | 2 | M710 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 2.07e-04 | 8 | 39 | 2 | MM14753 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.40e-04 | 44 | 39 | 3 | M26969 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.56e-04 | 45 | 39 | 3 | M47412 | |
| Pathway | WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA | 2.65e-04 | 9 | 39 | 2 | M39670 | |
| Pathway | WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER | 2.74e-04 | 46 | 39 | 3 | M46466 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 2.74e-04 | 46 | 39 | 3 | M47409 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.92e-04 | 47 | 39 | 3 | M39829 | |
| Pathway | PID_VEGF_VEGFR_PATHWAY | 3.31e-04 | 10 | 39 | 2 | M137 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.37e-04 | 121 | 39 | 4 | M39823 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 4.04e-04 | 11 | 39 | 2 | M27372 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 4.42e-04 | 130 | 39 | 4 | MM15455 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 4.69e-04 | 132 | 39 | 4 | M724 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.85e-04 | 140 | 39 | 4 | M587 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.31e-04 | 61 | 39 | 3 | M27103 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 6.65e-04 | 14 | 39 | 2 | MM14923 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 6.65e-04 | 14 | 39 | 2 | M47834 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 7.77e-04 | 151 | 39 | 4 | M19428 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 7.94e-04 | 66 | 39 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.94e-04 | 66 | 39 | 3 | M18 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 8.73e-04 | 16 | 39 | 2 | MM15605 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.11e-03 | 74 | 39 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.11e-03 | 74 | 39 | 3 | M16376 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 1.24e-03 | 19 | 39 | 2 | M47836 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 1.52e-03 | 21 | 39 | 2 | M103 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.54e-03 | 83 | 39 | 3 | M8728 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 1.54e-03 | 83 | 39 | 3 | M47961 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 1.89e-03 | 89 | 39 | 3 | M47963 | |
| Pathway | WNT_SIGNALING | 1.89e-03 | 89 | 39 | 3 | M5493 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.95e-03 | 90 | 39 | 3 | M835 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.95e-03 | 90 | 39 | 3 | M631 | |
| Pathway | WP_ANGIOGENESIS | 1.98e-03 | 24 | 39 | 2 | M39556 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 2.07e-03 | 92 | 39 | 3 | M47927 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.15e-03 | 25 | 39 | 2 | MM14940 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 2.15e-03 | 25 | 39 | 2 | M118 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.15e-03 | 25 | 39 | 2 | M39713 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 2.32e-03 | 26 | 39 | 2 | M39407 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.32e-03 | 26 | 39 | 2 | M27239 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.51e-03 | 27 | 39 | 2 | M27217 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 2.69e-03 | 28 | 39 | 2 | M77 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 2.69e-03 | 28 | 39 | 2 | M47835 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 2.71e-03 | 101 | 39 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 2.71e-03 | 101 | 39 | 3 | M39387 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.78e-03 | 102 | 39 | 3 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.78e-03 | 102 | 39 | 3 | MM15830 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.86e-03 | 103 | 39 | 3 | MM14752 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 2.89e-03 | 29 | 39 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 2.89e-03 | 29 | 39 | 2 | M47377 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 2.89e-03 | 29 | 39 | 2 | M55 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.09e-03 | 30 | 39 | 2 | M27772 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.10e-03 | 106 | 39 | 3 | M27077 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 3.30e-03 | 31 | 39 | 2 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 3.30e-03 | 31 | 39 | 2 | MM15154 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.51e-03 | 32 | 39 | 2 | MM14924 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.51e-03 | 32 | 39 | 2 | MM14854 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.20e-03 | 118 | 39 | 3 | M39852 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.43e-03 | 36 | 39 | 2 | M39699 | |
| Pathway | REACTOME_HEMOSTASIS | 4.49e-03 | 571 | 39 | 6 | MM14472 | |
| Pathway | PID_FRA_PATHWAY | 4.67e-03 | 37 | 39 | 2 | M65 | |
| Pathway | WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER | 5.18e-03 | 39 | 39 | 2 | M46456 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.18e-03 | 39 | 39 | 2 | MM14601 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 5.38e-03 | 257 | 39 | 4 | MM15454 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 5.68e-03 | 261 | 39 | 4 | M1077 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.71e-03 | 41 | 39 | 2 | M27778 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 5.99e-03 | 42 | 39 | 2 | M174 | |
| Pathway | KEGG_BLADDER_CANCER | 5.99e-03 | 42 | 39 | 2 | M19096 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 6.27e-03 | 43 | 39 | 2 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 6.27e-03 | 43 | 39 | 2 | M53 | |
| Pathway | WP_GENES_CONTROLLING_NEPHROGENESIS | 6.56e-03 | 44 | 39 | 2 | M39891 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 6.56e-03 | 44 | 39 | 2 | MM15878 | |
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 24639464 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 18614759 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 2.04e-08 | 21 | 49 | 4 | 21337463 | |
| Pubmed | 5.08e-08 | 26 | 49 | 4 | 20978081 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATRN CRELD1 THADA FBN2 TENM3 LRP1 LRP4 LRP6 LAMB2 ST3GAL2 LRP1B ITGB4 | 7.71e-08 | 1201 | 49 | 12 | 35696571 |
| Pubmed | CYR61 (CCN1) is essential for placental development and vascular integrity. | 9.16e-08 | 7 | 49 | 3 | 12446788 | |
| Pubmed | 1.74e-07 | 175 | 49 | 6 | 28071719 | ||
| Pubmed | 3.06e-07 | 40 | 49 | 4 | 27068110 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.22e-07 | 101 | 49 | 5 | 23382219 | |
| Pubmed | 4.53e-07 | 44 | 49 | 4 | 23884445 | ||
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 19833888 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.36e-06 | 135 | 49 | 5 | 28675934 | |
| Pubmed | Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs. | 1.45e-06 | 16 | 49 | 3 | 17187775 | |
| Pubmed | 1.49e-06 | 59 | 49 | 4 | 21421844 | ||
| Pubmed | 1.65e-06 | 257 | 49 | 6 | 16335952 | ||
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 21704027 | ||
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 10428027 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23137522 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 33162828 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18824633 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.94e-06 | 2 | 49 | 2 | 15963947 | |
| Pubmed | Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. | 1.94e-06 | 2 | 49 | 2 | 12594815 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18200665 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21525162 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22206010 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23243026 | ||
| Pubmed | Absence of CD9 reduces endometrial VEGF secretion and impairs uterine repair after parturition. | 1.94e-06 | 2 | 49 | 2 | 24736431 | |
| Pubmed | Genomic Landscapes of Noncoding RNAs Regulating VEGFA and VEGFC Expression in Endothelial Cells. | 1.94e-06 | 2 | 49 | 2 | 33875575 | |
| Pubmed | Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients. | 1.94e-06 | 2 | 49 | 2 | 24254563 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24146275 | ||
| Pubmed | Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. | 1.94e-06 | 2 | 49 | 2 | 17068288 | |
| Pubmed | The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas. | 1.94e-06 | 2 | 49 | 2 | 19347725 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21374591 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18057235 | ||
| Pubmed | The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. | 1.94e-06 | 2 | 49 | 2 | 19828679 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28925057 | ||
| Pubmed | Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer. | 1.94e-06 | 2 | 49 | 2 | 24638982 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28991900 | ||
| Pubmed | Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines. | 1.94e-06 | 2 | 49 | 2 | 26313304 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20107934 | ||
| Pubmed | Serum levels of VEGF and VEGF-C in patients with endometrial cancer. | 1.94e-06 | 2 | 49 | 2 | 21411409 | |
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 1.94e-06 | 2 | 49 | 2 | 26031789 | |
| Pubmed | Gene expression for VEGF-A, VEGF-C, and their receptors in murine lymphocytes and macrophages. | 1.94e-06 | 2 | 49 | 2 | 18205601 | |
| Pubmed | Distinct roles of VEGF-A and VEGF-C in tumour metastasis of gastric carcinoma. | 1.94e-06 | 2 | 49 | 2 | 17203176 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17353919 | ||
| Pubmed | Vascular endothelial growth factor A and C gene expression in endometriosis. | 1.94e-06 | 2 | 49 | 2 | 15668894 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 37596456 | ||
| Pubmed | VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. | 1.94e-06 | 2 | 49 | 2 | 17409493 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26269515 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15173661 | ||
| Pubmed | Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. | 1.94e-06 | 2 | 49 | 2 | 15896317 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28252641 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19291182 | ||
| Pubmed | VEGF Pathways in the Lymphatics of Healthy and Diseased Heart. | 1.94e-06 | 2 | 49 | 2 | 26190445 | |
| Pubmed | Vascular endothelial growth factor signaling in acute myeloid leukemia. | 1.94e-06 | 2 | 49 | 2 | 22833169 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19041000 | ||
| Pubmed | Coronary development is regulated by ATP-dependent SWI/SNF chromatin remodeling component BAF180. | 3.43e-06 | 21 | 49 | 3 | 18508041 | |
| Pubmed | The transcription factor Maz is essential for normal eye development. | 3.43e-06 | 21 | 49 | 3 | 32571845 | |
| Pubmed | Complexes of tetraspanins with integrins: more than meets the eye. | 5.21e-06 | 24 | 49 | 3 | 11739647 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15009103 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18509004 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16467091 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20864667 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18261985 | ||
| Pubmed | IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis. | 5.83e-06 | 3 | 49 | 2 | 27960151 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 33080605 | ||
| Pubmed | [Clinical significance of HIF-1 alpha,VEGF and VEGF-C expression in papillary thyroid carcinoma]. | 5.83e-06 | 3 | 49 | 2 | 17536453 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21698469 | ||
| Pubmed | CD137 signaling induces macrophage M2 polarization in atherosclerosis through STAT6/PPARδ pathway. | 5.83e-06 | 3 | 49 | 2 | 32247042 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23350126 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20133819 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25328912 | ||
| Pubmed | Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia. | 5.83e-06 | 3 | 49 | 2 | 28524736 | |
| Pubmed | Salivary gland tumours: immunoexpression of integrins beta 1, beta 3 and beta 4. | 5.83e-06 | 3 | 49 | 2 | 12694355 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19910455 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23086933 | ||
| Pubmed | The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. | 5.83e-06 | 3 | 49 | 2 | 22082308 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9689915 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15344881 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 5.83e-06 | 3 | 49 | 2 | 15316072 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19302703 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23059773 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 10711425 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21905955 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21556948 | ||
| Pubmed | Angiogenic and lymphangiogenic molecules in hematological malignancies. | 5.83e-06 | 3 | 49 | 2 | 11999550 | |
| Pubmed | Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. | 5.83e-06 | 3 | 49 | 2 | 11866538 | |
| Pubmed | Structural determinants of growth factor binding and specificity by VEGF receptor 2. | 5.83e-06 | 3 | 49 | 2 | 20145116 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16049374 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22407444 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21940662 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26621525 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9012504 | ||
| Pubmed | Serum vascular endothelial growth factors a, C and d in human breast tumors. | 5.83e-06 | 3 | 49 | 2 | 19821158 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18640270 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17148604 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20306691 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21282654 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22808199 | ||
| Pubmed | Smad4 Inhibits VEGF-A and VEGF-C Expressions via Enhancing Smad3 Phosphorylation in Colon Cancer. | 5.83e-06 | 3 | 49 | 2 | 28445620 | |
| Interaction | IGFL3 interactions | 2.35e-08 | 75 | 48 | 6 | int:IGFL3 | |
| Interaction | PTPRK interactions | 1.95e-07 | 177 | 48 | 7 | int:PTPRK | |
| Interaction | LRP5 interactions | 2.22e-07 | 109 | 48 | 6 | int:LRP5 | |
| Interaction | ZFP41 interactions | 2.36e-07 | 57 | 48 | 5 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 1.25e-05 | 60 | 48 | 4 | int:ANKRD36B | |
| Interaction | MANEA interactions | 1.25e-05 | 60 | 48 | 4 | int:MANEA | |
| Interaction | THBS1 interactions | 1.27e-05 | 127 | 48 | 5 | int:THBS1 | |
| Interaction | LRP6 interactions | 1.31e-05 | 128 | 48 | 5 | int:LRP6 | |
| Interaction | ZNF224 interactions | 1.41e-05 | 20 | 48 | 3 | int:ZNF224 | |
| Interaction | LCOR interactions | 2.27e-05 | 242 | 48 | 6 | int:LCOR | |
| Interaction | ZNF408 interactions | 2.40e-05 | 145 | 48 | 5 | int:ZNF408 | |
| Interaction | NTN5 interactions | 2.48e-05 | 24 | 48 | 3 | int:NTN5 | |
| Interaction | FBXO2 interactions | 4.99e-05 | 411 | 48 | 7 | int:FBXO2 | |
| Interaction | VEGFB interactions | 7.20e-05 | 34 | 48 | 3 | int:VEGFB | |
| Interaction | ATP11A interactions | 7.87e-05 | 35 | 48 | 3 | int:ATP11A | |
| Interaction | MYOF interactions | 1.01e-04 | 102 | 48 | 4 | int:MYOF | |
| Interaction | CRISP2 interactions | 1.18e-04 | 40 | 48 | 3 | int:CRISP2 | |
| Interaction | ST14 interactions | 1.30e-04 | 207 | 48 | 5 | int:ST14 | |
| Interaction | TAFAZZIN interactions | 1.30e-04 | 207 | 48 | 5 | int:TAFAZZIN | |
| Interaction | CNIH4 interactions | 1.68e-04 | 45 | 48 | 3 | int:CNIH4 | |
| Interaction | OS9 interactions | 1.69e-04 | 219 | 48 | 5 | int:OS9 | |
| Interaction | PIEZO1 interactions | 1.91e-04 | 47 | 48 | 3 | int:PIEZO1 | |
| Interaction | TAFA2 interactions | 1.91e-04 | 47 | 48 | 3 | int:TAFA2 | |
| Interaction | SLC39A6 interactions | 2.02e-04 | 122 | 48 | 4 | int:SLC39A6 | |
| Interaction | ITGA5 interactions | 2.36e-04 | 127 | 48 | 4 | int:ITGA5 | |
| Interaction | PTPRB interactions | 2.44e-04 | 51 | 48 | 3 | int:PTPRB | |
| Interaction | PCNX4 interactions | 2.47e-04 | 10 | 48 | 2 | int:PCNX4 | |
| Interaction | PTGFRN interactions | 2.58e-04 | 52 | 48 | 3 | int:PTGFRN | |
| Interaction | CLU interactions | 2.85e-04 | 245 | 48 | 5 | int:CLU | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q34 | 4.18e-05 | 61 | 50 | 3 | chr4q34 | |
| Cytoband | 4q34.3 | 7.62e-05 | 12 | 50 | 2 | 4q34.3 | |
| GeneFamily | Low density lipoprotein receptors | 9.34e-09 | 13 | 36 | 4 | 634 | |
| GeneFamily | CD molecules|Integrin beta subunits | 6.04e-07 | 9 | 36 | 3 | 1159 | |
| GeneFamily | CD molecules|Tetraspanins | 3.80e-05 | 33 | 36 | 3 | 768 | |
| GeneFamily | VEGF family | 3.84e-05 | 5 | 36 | 2 | 1267 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.15e-04 | 394 | 36 | 6 | 471 | |
| GeneFamily | Laminin subunits | 2.51e-04 | 12 | 36 | 2 | 626 | |
| GeneFamily | Wnt family|Endogenous ligands | 6.45e-04 | 19 | 36 | 2 | 360 | |
| GeneFamily | Fibronectin type III domain containing | 3.92e-03 | 160 | 36 | 3 | 555 | |
| Coexpression | NABA_MATRISOME | VEGFC CRELD1 FBN2 WNT7B WNT8A LAMA3 LAMB2 ESM1 CTSB TNXB FBN3 VEGFA | 3.72e-07 | 1026 | 50 | 12 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 8.81e-07 | 275 | 50 | 7 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.96e-06 | 196 | 50 | 6 | M3008 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.20e-06 | 200 | 50 | 6 | M5930 | |
| Coexpression | NABA_MATRISOME | VEGFC CRELD1 FBN2 WNT7B WNT8A LAMA3 LAMB2 ESM1 CTSB TNXB VEGFA | 2.43e-06 | 1008 | 50 | 11 | MM17056 |
| Coexpression | SAUL_SEN_MAYO | 3.75e-06 | 123 | 50 | 5 | MM16098 | |
| Coexpression | SAUL_SEN_MAYO | 3.90e-06 | 124 | 50 | 5 | M45803 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.04e-05 | 71 | 50 | 4 | M2948 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.13e-05 | 23 | 50 | 3 | M48001 | |
| Coexpression | NABA_CORE_MATRISOME | 1.23e-05 | 270 | 50 | 6 | MM17057 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.47e-05 | 780 | 50 | 9 | M2324 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.48e-05 | 163 | 50 | 5 | M12112 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.88e-05 | 805 | 50 | 9 | MM1067 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | 2.12e-05 | 1033 | 50 | 10 | M4196 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 2.82e-05 | 313 | 50 | 6 | M39128 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 3.12e-05 | 32 | 50 | 3 | M308 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.17e-05 | 191 | 50 | 5 | MM17059 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN | 3.50e-05 | 195 | 50 | 5 | M9309 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 3.85e-05 | 199 | 50 | 5 | M7448 | |
| Coexpression | GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP | 3.94e-05 | 200 | 50 | 5 | M7826 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 6.94e-05 | 368 | 50 | 6 | M16431 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 7.34e-05 | 228 | 50 | 5 | MM3676 | |
| Coexpression | KORKOLA_SEMINOMA_UP | 8.19e-05 | 44 | 50 | 3 | M18387 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 1.03e-04 | 574 | 50 | 7 | M39056 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 1.11e-04 | 130 | 50 | 4 | M17428 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 1.15e-04 | 131 | 50 | 4 | M40316 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_UP | 1.20e-04 | 50 | 50 | 3 | M10372 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_UP | 1.35e-04 | 52 | 50 | 3 | M6225 | |
| Coexpression | HALLMARK_COAGULATION | 1.40e-04 | 138 | 50 | 4 | M5946 | |
| Coexpression | MEL18_DN.V1_UP | 1.52e-04 | 141 | 50 | 4 | M2784 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | 1.59e-04 | 269 | 50 | 5 | M39114 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_UP | 1.70e-04 | 145 | 50 | 4 | M2779 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.80e-04 | 276 | 50 | 5 | M3063 | |
| Coexpression | AGARWAL_AKT_PATHWAY_TARGETS | 1.94e-04 | 11 | 50 | 2 | M3495 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 2.02e-04 | 283 | 50 | 5 | M39117 | |
| Coexpression | TENEDINI_MEGAKARYOCYTE_MARKERS | 2.28e-04 | 62 | 50 | 3 | M6752 | |
| Coexpression | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP | 2.47e-04 | 160 | 50 | 4 | M986 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS | 2.75e-04 | 66 | 50 | 3 | M40274 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.90e-04 | 479 | 50 | 6 | M2573 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 2.99e-04 | 909 | 50 | 8 | M41018 | |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_UP | 3.00e-04 | 68 | 50 | 3 | M1549 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 3.04e-04 | 483 | 50 | 6 | MM1082 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 3.39e-04 | 493 | 50 | 6 | M19391 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 3.40e-04 | 174 | 50 | 4 | M45676 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 3.81e-04 | 325 | 50 | 5 | M39053 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 3.85e-04 | 505 | 50 | 6 | M39167 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 4.33e-04 | 77 | 50 | 3 | M19128 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 4.65e-04 | 189 | 50 | 4 | M45678 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | 5.07e-04 | 746 | 50 | 7 | M40863 | |
| Coexpression | P53_DN.V1_UP | 5.13e-04 | 194 | 50 | 4 | M2698 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP | 5.54e-04 | 198 | 50 | 4 | M7702 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN | 5.54e-04 | 198 | 50 | 4 | M8750 | |
| Coexpression | HINATA_NFKB_TARGETS_KERATINOCYTE_UP | 5.58e-04 | 84 | 50 | 3 | M11951 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 5.65e-04 | 199 | 50 | 4 | M8113 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP | 5.65e-04 | 199 | 50 | 4 | M7766 | |
| Coexpression | GSE30083_SP1_VS_SP3_THYMOCYTE_UP | 5.65e-04 | 199 | 50 | 4 | M5025 | |
| Coexpression | GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN | 5.65e-04 | 199 | 50 | 4 | M8356 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN | 5.65e-04 | 199 | 50 | 4 | M9599 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN | 5.65e-04 | 199 | 50 | 4 | M9913 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP | 5.65e-04 | 199 | 50 | 4 | M9918 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 5.76e-04 | 200 | 50 | 4 | M9313 | |
| Coexpression | GSE27786_NKTCELL_VS_MONO_MAC_UP | 5.76e-04 | 200 | 50 | 4 | M4870 | |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 5.76e-04 | 200 | 50 | 4 | M8217 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP | 5.76e-04 | 200 | 50 | 4 | M7234 | |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN | 5.76e-04 | 200 | 50 | 4 | M9957 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_12H_BMDC_UP | 5.76e-04 | 200 | 50 | 4 | M3948 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN | 5.76e-04 | 200 | 50 | 4 | M7453 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP | 5.76e-04 | 200 | 50 | 4 | M7499 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP | 5.76e-04 | 200 | 50 | 4 | M7501 | |
| Coexpression | GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 5.76e-04 | 200 | 50 | 4 | M6209 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 6.22e-04 | 362 | 50 | 5 | M39176 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 6.38e-04 | 364 | 50 | 5 | M39057 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 6.45e-04 | 365 | 50 | 5 | M39018 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 6.53e-04 | 366 | 50 | 5 | M2461 | |
| Coexpression | DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS | 6.61e-04 | 89 | 50 | 3 | M40105 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 6.63e-04 | 20 | 50 | 2 | MM17053 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 7.55e-04 | 378 | 50 | 5 | MM1077 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | 8.62e-04 | 589 | 50 | 6 | M45662 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 9.58e-04 | 24 | 50 | 2 | MM627 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 9.58e-04 | 24 | 50 | 2 | M1437 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 4.31e-06 | 105 | 49 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 6.73e-06 | 115 | 49 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | 6.02e-05 | 774 | 49 | 9 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | 6.02e-05 | 774 | 49 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 7.11e-05 | 96 | 49 | 4 | GSM777063_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 7.82e-05 | 455 | 49 | 7 | GSM777055_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.92e-05 | 192 | 49 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | 9.11e-05 | 817 | 49 | 9 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_500 | 1.08e-04 | 107 | 49 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.66e-04 | 514 | 49 | 7 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k4_1000 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 | CPEB2 ATRN CD9 AGA LAMA3 ATP10B SERINC2 PPARD CTSB ITPK1 VEGFA | 1.87e-04 | 1337 | 49 | 11 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 |
| CoexpressionAtlas | thyroid gland | 2.25e-04 | 240 | 49 | 5 | thyroid gland | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 2.44e-04 | 384 | 49 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.77e-04 | 251 | 49 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3 | 2.88e-04 | 396 | 49 | 6 | GSM605799_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.13e-04 | 570 | 49 | 7 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.31e-04 | 261 | 49 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | 3.54e-04 | 772 | 49 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.76e-04 | 148 | 49 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 3.83e-04 | 990 | 49 | 9 | JC_hmvEC_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 4.56e-04 | 65 | 49 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 4.59e-04 | 156 | 49 | 4 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_200 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.70e-04 | 157 | 49 | 4 | JC_iEC_1000_K3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 4.86e-04 | 437 | 49 | 6 | GSM777046_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | 5.16e-04 | 817 | 49 | 8 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 5.54e-04 | 164 | 49 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | 5.78e-04 | 831 | 49 | 8 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 6.06e-04 | 298 | 49 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 6.07e-04 | 456 | 49 | 6 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 6.29e-04 | 459 | 49 | 6 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 6.50e-04 | 846 | 49 | 8 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 6.55e-04 | 847 | 49 | 8 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | 6.70e-04 | 850 | 49 | 8 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 6.80e-04 | 466 | 49 | 6 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_200 | 7.22e-04 | 176 | 49 | 4 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_200 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 7.78e-04 | 78 | 49 | 3 | ratio_EB_vs_SC_500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_200 | 7.86e-04 | 180 | 49 | 4 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_200 | 8.19e-04 | 182 | 49 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_200 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24int.Th, 4+ 8- TCRhi 24int, Thymus, avg-3 | 8.82e-04 | 324 | 49 | 5 | GSM399373_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | 9.31e-04 | 495 | 49 | 6 | JC_hmvEC_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_100 | 9.65e-04 | 84 | 49 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_200 | 9.65e-04 | 20 | 49 | 2 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_200_k5 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 1.01e-03 | 905 | 49 | 8 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500 | 1.03e-03 | 86 | 49 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 1.10e-03 | 88 | 49 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.14e-03 | 199 | 49 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_500 | 1.22e-03 | 91 | 49 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k4 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.22e-03 | 91 | 49 | 3 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.24e-03 | 523 | 49 | 6 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.24e-03 | 523 | 49 | 6 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.25e-03 | 936 | 49 | 8 | JC_hmvEC_2500_K1 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.30e-03 | 93 | 49 | 3 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k3_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.34e-03 | 94 | 49 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.37e-03 | 209 | 49 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.38e-03 | 95 | 49 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | 1.39e-03 | 734 | 49 | 7 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 1.50e-03 | 365 | 49 | 5 | GSM399376_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 1.62e-03 | 975 | 49 | 8 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.62e-03 | 219 | 49 | 4 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000 | 1.65e-03 | 978 | 49 | 8 | PCBC_ctl_CardioEndothel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 1.75e-03 | 378 | 49 | 5 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_1000 | 1.79e-03 | 990 | 49 | 8 | PCBC_ctl_BronchioEpithel_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 1.83e-03 | 382 | 49 | 5 | GSM476684_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.93e-03 | 571 | 49 | 6 | JC_fibro_2500_K1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.94e-03 | 107 | 49 | 3 | JC_hmvEC_1000_K1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 1.96e-03 | 388 | 49 | 5 | GSM605790_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 1.96e-03 | 388 | 49 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | 1.96e-03 | 388 | 49 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-09 | 183 | 50 | 7 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-09 | 192 | 50 | 7 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-09 | 192 | 50 | 7 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-09 | 193 | 50 | 7 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.56e-08 | 169 | 50 | 6 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-08 | 170 | 50 | 6 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-08 | 170 | 50 | 6 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 4.85e-08 | 178 | 50 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.35e-08 | 181 | 50 | 6 | 72c28baf4fd417ff4a7068603830d55074960144 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-08 | 181 | 50 | 6 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.35e-08 | 181 | 50 | 6 | 2ac4d3e8987d5a009d7908d8787e18165826202a | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.35e-08 | 181 | 50 | 6 | 2628c7ac345eaaeecf8e34617e81948925962cb9 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-08 | 183 | 50 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-08 | 187 | 50 | 6 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-08 | 187 | 50 | 6 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-08 | 187 | 50 | 6 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-08 | 187 | 50 | 6 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 6.70e-08 | 188 | 50 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-08 | 189 | 50 | 6 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.92e-08 | 189 | 50 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.14e-08 | 190 | 50 | 6 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.14e-08 | 190 | 50 | 6 | 9b0ad888eb20acc011904d8593bc32bdef18d050 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 0e8a73f01e3ec95d242c09231bcf3790324d0a67 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 54bbccc554f43ba2ebdf9ea191b94c8f16081b53 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.36e-08 | 191 | 50 | 6 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-08 | 192 | 50 | 6 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-08 | 192 | 50 | 6 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.83e-08 | 193 | 50 | 6 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | droplet-Lung-21m-Endothelial-venous_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.07e-08 | 194 | 50 | 6 | db7b0c77ad88f7b74d85679f1fb8ee7140ac3f62 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-08 | 194 | 50 | 6 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.07e-08 | 194 | 50 | 6 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.07e-08 | 194 | 50 | 6 | 17d530982789acc5e6889b215f3d433d138a41c4 | |
| ToppCell | droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.07e-08 | 194 | 50 | 6 | 5992b9409d5855eff2afc3acd201ccd25420d2e0 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.32e-08 | 195 | 50 | 6 | 0c15be3e7c238e329505dcbbe197a977d1019d45 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.32e-08 | 195 | 50 | 6 | 45ac0fdbeb0982d798c613a6d15715d725608aa9 | |
| ToppCell | droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.32e-08 | 195 | 50 | 6 | 5b1f04a745467876b09113ee17ababd3fcf9fb01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-08 | 197 | 50 | 6 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.11e-08 | 198 | 50 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.38e-08 | 199 | 50 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.38e-08 | 199 | 50 | 6 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-08 | 200 | 50 | 6 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.66e-08 | 200 | 50 | 6 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 164 | 50 | 5 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-06 | 170 | 50 | 5 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-06 | 171 | 50 | 5 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 171 | 50 | 5 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-06 | 172 | 50 | 5 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-06 | 172 | 50 | 5 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 1.42e-06 | 172 | 50 | 5 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-06 | 173 | 50 | 5 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 1.50e-06 | 174 | 50 | 5 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-06 | 174 | 50 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 175 | 50 | 5 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 175 | 50 | 5 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-06 | 176 | 50 | 5 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 1.59e-06 | 176 | 50 | 5 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-06 | 177 | 50 | 5 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 178 | 50 | 5 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 178 | 50 | 5 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-06 | 178 | 50 | 5 | ebfae386a518ea33911ba3ff40464c94d18ef695 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-06 | 178 | 50 | 5 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.68e-06 | 178 | 50 | 5 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-06 | 178 | 50 | 5 | 87b04753650e45f12299c8456fb980d6c0d5961c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.68e-06 | 178 | 50 | 5 | b1357ceb84b83fab53c0394c1af73cbd009f571a | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 1.73e-06 | 179 | 50 | 5 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-06 | 180 | 50 | 5 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-06 | 180 | 50 | 5 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-06 | 180 | 50 | 5 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-06 | 182 | 50 | 5 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.87e-06 | 182 | 50 | 5 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.93e-06 | 183 | 50 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.98e-06 | 184 | 50 | 5 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 1.98e-06 | 184 | 50 | 5 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-06 | 184 | 50 | 5 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-06 | 184 | 50 | 5 | 3b0389c3a5a16697de860e98ebc48ed39ede646f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-06 | 185 | 50 | 5 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-06 | 185 | 50 | 5 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-06 | 185 | 50 | 5 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-06 | 185 | 50 | 5 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 186 | 50 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-06 | 186 | 50 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-06 | 186 | 50 | 5 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 186 | 50 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-06 | 186 | 50 | 5 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 2.08e-06 | 186 | 50 | 5 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-06 | 186 | 50 | 5 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-06 | 187 | 50 | 5 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|tumor_Lung / Location, Cell class and cell subclass | 2.14e-06 | 187 | 50 | 5 | 87ecdc5f24aced95a37e653429f0fc493ff4aa3e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-06 | 187 | 50 | 5 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-06 | 187 | 50 | 5 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-06 | 188 | 50 | 5 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 188 | 50 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.20e-06 | 188 | 50 | 5 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 2.20e-06 | 188 | 50 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Endothelial-B|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-06 | 188 | 50 | 5 | 5959a88728812a5f4cbfa54eddc7a73ccbaa2f68 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.20e-06 | 188 | 50 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-06 | 188 | 50 | 5 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.19e-05 | 50 | 36 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2 | |
| Computational | Adhesion molecules. | 9.83e-05 | 141 | 36 | 5 | MODULE_122 | |
| Drug | Rgd Peptide | 1.90e-09 | 239 | 49 | 9 | CID000104802 | |
| Drug | monatepil | 4.32e-07 | 29 | 49 | 4 | CID000060810 | |
| Drug | trypanothione disulfide | 5.46e-07 | 140 | 49 | 6 | CID000115098 | |
| Drug | YIGSR | 7.48e-07 | 79 | 49 | 5 | CID000123977 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 9.92e-07 | 155 | 49 | 6 | 6817_DN | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.99e-06 | 197 | 49 | 6 | 4842_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 3.99e-06 | 197 | 49 | 6 | 7476_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.99e-06 | 197 | 49 | 6 | 5638_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.99e-06 | 197 | 49 | 6 | 5335_UP | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.99e-06 | 197 | 49 | 6 | 7472_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.11e-06 | 198 | 49 | 6 | 5500_UP | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.11e-06 | 198 | 49 | 6 | 1510_DN | |
| Drug | pitavastatin | 4.61e-06 | 114 | 49 | 5 | CID005282451 | |
| Drug | N-octanoyl-beta-D-glucosylamine | 6.24e-06 | 17 | 49 | 3 | CID000151803 | |
| Drug | N-aminoimidazole | 1.36e-05 | 3 | 49 | 2 | CID005273583 | |
| Drug | troglitazone | 1.51e-05 | 526 | 49 | 8 | CID000005591 | |
| Drug | ezetimibe | 1.59e-05 | 147 | 49 | 5 | CID000150311 | |
| Drug | DITPA | 1.84e-05 | 24 | 49 | 3 | CID000160565 | |
| Drug | Betamethasone-d5 | VEGFC KLK15 LRP1 LAMA3 LAMB2 PPARD CTSB ITGB3 ITGB4 ITGB7 FBN3 VEGFA | 1.99e-05 | 1340 | 49 | 12 | CID000003003 |
| Drug | BIBX1382BS | 2.35e-05 | 26 | 49 | 3 | CID006918508 | |
| Drug | urushiol | 4.52e-05 | 5 | 49 | 2 | ctd:C003747 | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 5.44e-05 | 190 | 49 | 5 | 2911_UP | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 5.57e-05 | 191 | 49 | 5 | 1211_UP | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 5255_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 1480_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 4538_UP | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 3401_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 3346_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 3327_UP | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 4172_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 3452_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; PC3; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 4656_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 2798_UP | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 5407_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 5404_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 5205_DN | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 7335_UP | |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; ssMCF7; HG-U133A | 6.30e-05 | 196 | 49 | 5 | 500_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 5009_UP | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 3681_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 3355_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 6656_UP | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 3259_DN | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5991_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 6486_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 3749_DN | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 3101_UP | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 4946_DN | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 6767_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 4749_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; HL60; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 2451_DN | |
| Drug | caroverine | 6.77e-05 | 6 | 49 | 2 | CID000065709 | |
| Drug | BAPSG | 6.77e-05 | 6 | 49 | 2 | CID000130998 | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 6.93e-05 | 200 | 49 | 5 | 3030_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; MCF7; HT_HG-U133A | 6.93e-05 | 200 | 49 | 5 | 2642_UP | |
| Drug | calcium carbonate | 7.44e-05 | 203 | 49 | 5 | CID000010112 | |
| Drug | 17alpha-estradiol | WNT7B WNT8A LRP1 LRP4 LRP6 PPARD CTSB LRP1B ITGB3 ITPK1 VEGFA | 8.04e-05 | 1303 | 49 | 11 | CID000000450 |
| Drug | Diethylstilbestrol | TNFRSF9 FCGBP FBN2 CD9 WNT7B CTSB ITGB3 ITGB7 ITPK1 DNMT3A VEGFA | 8.15e-05 | 1305 | 49 | 11 | ctd:D004054 |
| Drug | Gdrgdsp | 8.92e-05 | 109 | 49 | 4 | CID000115346 | |
| Drug | isocycloheximide | 1.17e-04 | 905 | 49 | 9 | CID000002900 | |
| Drug | AC1L1J6H | 1.51e-04 | 236 | 49 | 5 | CID000004889 | |
| Drug | 1pxl | 1.61e-04 | 49 | 49 | 3 | CID000447958 | |
| Drug | coprogen | 1.62e-04 | 9 | 49 | 2 | CID006323272 | |
| Drug | 1,2-dioleoyloxy-3-(trimethylammonium)propane | 2.15e-04 | 54 | 49 | 3 | ctd:C070046 | |
| Drug | AC1L2UHE | 2.27e-04 | 55 | 49 | 3 | CID000128814 | |
| Drug | kalinin | 2.27e-04 | 55 | 49 | 3 | CID000032518 | |
| Drug | AC1L1G72 | 2.46e-04 | 11 | 49 | 2 | CID000003553 | |
| Drug | AC1O6ABO | 2.46e-04 | 11 | 49 | 2 | CID006449889 | |
| Drug | BM165 | 2.46e-04 | 11 | 49 | 2 | CID003352881 | |
| Drug | 1xqc | 2.46e-04 | 11 | 49 | 2 | CID005287617 | |
| Drug | hyaluronan | 2.49e-04 | 263 | 49 | 5 | CID000024759 | |
| Drug | CC270 | 2.80e-04 | 59 | 49 | 3 | CID006918852 | |
| Drug | AC1L9INI | 2.80e-04 | 59 | 49 | 3 | CID000445839 | |
| Drug | 12 p | 3.01e-04 | 274 | 49 | 5 | CID000081248 | |
| Drug | Calpain inhibitor I | 3.33e-04 | 280 | 49 | 5 | CID000004332 | |
| Drug | indole-3-acetyl-l-valine | 3.73e-04 | 65 | 49 | 3 | CID000446641 | |
| Drug | Cycloheximide | 3.75e-04 | 446 | 49 | 6 | ctd:D003513 | |
| Drug | 25-hydroxycholesterol | 3.89e-04 | 160 | 49 | 4 | CID000065094 | |
| Drug | N-methylformamide | 3.90e-04 | 66 | 49 | 3 | CID000031254 | |
| Drug | Triton X-100 | 3.90e-04 | 66 | 49 | 3 | CID000005590 | |
| Drug | Sz 1 | 4.06e-04 | 14 | 49 | 2 | CID000132551 | |
| Drug | 2f1b | 4.07e-04 | 67 | 49 | 3 | CID011963508 | |
| Drug | probucol | 4.08e-04 | 162 | 49 | 4 | CID000004912 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 4.08e-04 | 162 | 49 | 4 | CID000072363 | |
| Drug | Furosemide | 4.27e-04 | 164 | 49 | 4 | ctd:D005665 | |
| Drug | Oxytetracycline | 4.68e-04 | 15 | 49 | 2 | ctd:D010118 | |
| Drug | mono-(2-ethylhexyl)phthalate | 4.88e-04 | 658 | 49 | 7 | ctd:C016599 | |
| Drug | LMWH | 5.10e-04 | 663 | 49 | 7 | CID000000772 | |
| Drug | 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 5.34e-04 | 16 | 49 | 2 | ctd:D019377 | |
| Drug | genistein | 5.56e-04 | 1117 | 49 | 9 | CID005280961 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 5.61e-04 | 314 | 49 | 5 | CID000447989 | |
| Drug | P-29 | 5.67e-04 | 75 | 49 | 3 | CID000200890 | |
| Drug | pararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.69e-04 | 177 | 49 | 4 | 893_UP | |
| Drug | apricitabine | 6.04e-04 | 17 | 49 | 2 | CID000455041 | |
| Drug | AMD3100 | 6.13e-04 | 77 | 49 | 3 | CID000065014 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 6.19e-04 | 181 | 49 | 4 | 1236_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 6.32e-04 | 182 | 49 | 4 | 1663_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.45e-04 | 183 | 49 | 4 | 1475_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.72e-04 | 185 | 49 | 4 | 6243_UP | |
| Drug | boldenone | 6.79e-04 | 18 | 49 | 2 | CID000013308 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.06e-06 | 107 | 50 | 5 | DOID:11054 (is_marker_for) | |
| Disease | Hemangiosarcoma | 3.67e-06 | 18 | 50 | 3 | C0018923 | |
| Disease | connective tissue disease (implicated_via_orthology) | 8.43e-06 | 3 | 50 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Clear-cell metastatic renal cell carcinoma | 1.68e-05 | 4 | 50 | 2 | C2931852 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.68e-05 | 4 | 50 | 2 | C0079297 | |
| Disease | Herlitz Disease | 1.68e-05 | 4 | 50 | 2 | C0079683 | |
| Disease | coronary artery disease | 2.66e-05 | 1194 | 50 | 10 | EFO_0001645 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 2.80e-05 | 5 | 50 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 2.80e-05 | 5 | 50 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 2.80e-05 | 5 | 50 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 4.20e-05 | 6 | 50 | 2 | C0079301 | |
| Disease | Pathologic Neovascularization | 4.20e-05 | 6 | 50 | 2 | C0027686 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 5.88e-05 | 7 | 50 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 7.66e-05 | 616 | 50 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.66e-05 | 616 | 50 | 7 | C0376358 | |
| Disease | pterygium (is_marker_for) | 1.01e-04 | 9 | 50 | 2 | DOID:0002116 (is_marker_for) | |
| Disease | renal Wilms' tumor (is_implicated_in) | 1.26e-04 | 10 | 50 | 2 | DOID:5176 (is_implicated_in) | |
| Disease | intraocular pressure measurement | 2.14e-04 | 509 | 50 | 6 | EFO_0004695 | |
| Disease | intracranial aneurysm (is_marker_for) | 2.53e-04 | 14 | 50 | 2 | DOID:10941 (is_marker_for) | |
| Disease | prostate specific antigen measurement | 2.92e-04 | 188 | 50 | 4 | EFO_0004624 | |
| Disease | myocardial infarction | 3.12e-04 | 350 | 50 | 5 | EFO_0000612 | |
| Disease | Glioblastoma | 3.31e-04 | 79 | 50 | 3 | C0017636 | |
| Disease | Astrocytosis | 3.77e-04 | 17 | 50 | 2 | C3887640 | |
| Disease | Gliosis | 3.77e-04 | 17 | 50 | 2 | C0017639 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.96e-04 | 84 | 50 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Giant Cell Glioblastoma | 3.96e-04 | 84 | 50 | 3 | C0334588 | |
| Disease | optic disc size measurement | 4.06e-04 | 205 | 50 | 4 | EFO_0004832 | |
| Disease | Autism Spectrum Disorders | 4.10e-04 | 85 | 50 | 3 | C1510586 | |
| Disease | response to mepolizumab, Glucocorticoid use measurement | 4.23e-04 | 18 | 50 | 2 | EFO_0008459, EFO_0009942 | |
| Disease | left ventricular structural measurement | 4.54e-04 | 88 | 50 | 3 | EFO_0008205 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 6.96e-04 | 23 | 50 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 6.96e-04 | 23 | 50 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 6.96e-04 | 23 | 50 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 6.96e-04 | 23 | 50 | 2 | C0014556 | |
| Disease | Myasthenic Syndromes, Congenital | 7.58e-04 | 24 | 50 | 2 | C0751882 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 8.25e-04 | 108 | 50 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | myeloperoxidase measurement | 8.91e-04 | 26 | 50 | 2 | EFO_0005243 | |
| Disease | blood rubidium measurement | 8.91e-04 | 26 | 50 | 2 | EFO_0021529 | |
| Disease | Glioblastoma Multiforme | 8.93e-04 | 111 | 50 | 3 | C1621958 | |
| Disease | Cerebral Hemorrhage | 1.03e-03 | 28 | 50 | 2 | C2937358 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.04e-03 | 117 | 50 | 3 | EFO_0004518, EFO_0005208 | |
| Disease | cardiovascular disease | 1.04e-03 | 457 | 50 | 5 | EFO_0000319 | |
| Disease | hormone measurement, thyroid stimulating hormone measurement | 1.11e-03 | 29 | 50 | 2 | EFO_0004730, EFO_0004748 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 1.17e-03 | 122 | 50 | 3 | EFO_0004318, EFO_0007789 | |
| Disease | proteinuria (implicated_via_orthology) | 1.19e-03 | 30 | 50 | 2 | DOID:576 (implicated_via_orthology) | |
| Disease | hematocrit | 1.50e-03 | 1011 | 50 | 7 | EFO_0004348 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.52e-03 | 34 | 50 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 1.60e-03 | 136 | 50 | 3 | DOID:9352 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.69e-03 | 301 | 50 | 4 | DOID:684 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDLLTCCGSMCGDGC | 136 | P07858 | |
| CGGREVLMCGNNNCC | 541 | Q9Y6K1 | |
| SFPCGCSRDGCGNMA | 241 | Q9H175 | |
| CSRDGCGNMAGRIEF | 246 | Q9H175 | |
| SCGVSRGSGCSVSCM | 111 | Q75N90 | |
| RGSGCSVSCMNGGTC | 116 | Q75N90 | |
| SVSCMNGGTCRGASC | 121 | Q75N90 | |
| QRCGTECMRDDSCSG | 1401 | O94823 | |
| MDSGRCNLCGEESFG | 371 | Q15124 | |
| CRDCAKACLGCMGAG | 271 | Q96HD1 | |
| GERTCSASPGCCGSM | 351 | Q13572 | |
| CGAITCAADMFSCQG | 2756 | Q9NZR2 | |
| CQGCQCDIGGALSSM | 681 | Q16787 | |
| GTCQMAADGSRQCRC | 4316 | Q07954 | |
| SFDMCPNNCSGRGEC | 246 | O75882 | |
| MSENGSFANCCEAGG | 1 | P49286 | |
| TMVCAGAEGRGAESC | 191 | Q9H2R5 | |
| CGIDNGGCSHLCLMS | 286 | O75581 | |
| VCRSCDCDPMGSQDG | 406 | P55268 | |
| TSGFLCNDRGRCSMG | 546 | P16144 | |
| MNCKEGTDSSCGCRG | 1 | Q9H4E5 | |
| RTGRACECSGDMDSC | 591 | P26010 | |
| LGCCGAVQESQCMLG | 76 | P21926 | |
| MCDECQGARCGGKFA | 526 | Q7Z5Q1 | |
| EPSCEGMQCAAGQRC | 441 | Q9Y6R7 | |
| CAMCEREQCDGSVGF | 61 | P20933 | |
| DTCMSSNGLLCSGRG | 591 | P05106 | |
| TFGMDCRETCNCQSG | 106 | Q9NQ30 | |
| RNSCGDGFCSRPNMC | 116 | P35556 | |
| DGFCSRPNMCTCSSG | 121 | P35556 | |
| MDGGRTCSCSSFCRC | 81 | Q9NZY2 | |
| AAACTSALCCMGRNG | 1061 | Q9Y6K5 | |
| GSCNSRGALGALMAC | 586 | Q6YHU6 | |
| DQLQMGCDGASCGSL | 56 | Q03181 | |
| GCDGASCGSLNMECR | 61 | Q03181 | |
| RGSEAMAAGLCAGQC | 736 | Q8TCU6 | |
| SGKSCACRRCMGDAG | 66 | Q16842 | |
| SGDMQKQGCDCECLG | 61 | Q9NRX4 | |
| GMGNGCGRSNERSSC | 2266 | Q9H2D6 | |
| RTSPGADGCDTMCCG | 296 | P56706 | |
| ADGCDTMCCGRGYNT | 301 | P56706 | |
| RCGGCCNSEGLQCMN | 161 | P49767 | |
| TGDDCGMRSCPRGCS | 271 | P22105 | |
| GFHCLGAGCSMCEQD | 91 | Q07011 | |
| GAGCSMCEQDCKQGQ | 96 | Q07011 | |
| CAEGMEGNGTCSCQE | 126 | Q8WWQ8 | |
| QCGGRGICIMGSCAC | 586 | Q9P273 | |
| SCNNGEMCDRFQGCL | 316 | Q02763 | |
| AGDQTGGAFCMCDVS | 106 | Q6ZTR6 | |
| SSDFVGCAQGMCCHG | 66 | Q71RG6 | |
| MFRSQAGGACDCGDS | 161 | Q6ZT12 | |
| GCCGAMRESQCVLGS | 76 | O60636 | |
| TKNCSMGDFENCGCD | 101 | Q9H1J5 | |
| MRCGGCCNDEGLECV | 81 | P15692 | |
| NSDTIGCCGDDNGLM | 1406 | Q69YN4 | |
| MGACLGACSLLSCAS | 1 | Q96SA4 | |
| PDRCCMENSQGCGRN | 166 | O75954 | |
| CRSGEFMCDSGLCIN | 231 | O75096 |